Publication | Closed Access

Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women

Bone DiseaseBiochemical MarkersBone HealthPhysiologyGynecologyBone MassEarly Postmenopausal WomenMenopauseOsteoporosisBone DensityEndocrinologyMedicineOrthopaedic SurgeryBone MetabolismWomen's HealthHealth Sciences